OAM
CSCI

Oxford Asset Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Oxford Asset Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,312
Closed -$631K – 908
2015
Q4 		$631K Buy
+1,312
New +$824K 0.01% 635

Other funds holding CSCI

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oxford Asset Management's CSCI Position: Q1 2016 in Review

Oxford Asset Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2016, closing a stake of 1,312 shares — an estimated $631K sold.

Oxford Asset Management first reported a position in CSCI in Q4 2015 and held it in 1 quarter. The position peaked at $631K in Q4 2015. 14 funds tracked by Wall St. Rank hold CSCI as of Q1 2016.

  • Oxford Asset Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Oxford Asset Management sold 1,312 COSCIENS Biopharma Inc. Common Stock shares in Q1 2016, an estimated $631K.
  • Oxford Asset Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • Oxford Asset Management's COSCIENS Biopharma Inc. Common Stock position peaked at $631K in Q4 2015.
  • 14 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2016.

Based on Oxford Asset Management's 13F filing for Q1 2016, filed 9 May 2016.